These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 8804420)
1. Identification of nuclear localization signals within the zinc fingers of the WT1 tumor suppressor gene product. Bruening W; Moffett P; Chia S; Heinrich G; Pelletier J FEBS Lett; 1996 Sep; 393(1):41-7. PubMed ID: 8804420 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of the DNA-binding and transcriptional repression activity of the Wilms' tumor gene product, WT1, by cAMP-dependent protein kinase-mediated phosphorylation of Ser-365 and Ser-393 in the zinc finger domain. Sakamoto Y; Yoshida M; Semba K; Hunter T Oncogene; 1997 Oct; 15(17):2001-12. PubMed ID: 9366517 [TBL] [Abstract][Full Text] [Related]
3. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways. Wang ZY; Qiu QQ; Huang J; Gurrieri M; Deuel TF Oncogene; 1995 Feb; 10(3):415-22. PubMed ID: 7845666 [TBL] [Abstract][Full Text] [Related]
4. Truncated WT1 mutants alter the subnuclear localization of the wild-type protein. Englert C; Vidal M; Maheswaran S; Ge Y; Ezzell RM; Isselbacher KJ; Haber DA Proc Natl Acad Sci U S A; 1995 Dec; 92(26):11960-4. PubMed ID: 8618823 [TBL] [Abstract][Full Text] [Related]
5. Expression in Xenopus oocytes shows that WT1 binds transcripts in vivo, with a central role for zinc finger one. Ladomery M; Sommerville J; Woolner S; Slight J; Hastie N J Cell Sci; 2003 Apr; 116(Pt 8):1539-49. PubMed ID: 12640038 [TBL] [Abstract][Full Text] [Related]
6. A novel target for the Wilms' tumour suppressor protein (WT1) is bound by a unique combination of zinc fingers. Little MH; Holmes G; Pell L; Caricasole A; Duarte A; Law M; Ward A; Wainwright B Oncogene; 1996 Oct; 13(7):1461-9. PubMed ID: 8875984 [TBL] [Abstract][Full Text] [Related]
7. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. Maheswaran S; Englert C; Bennett P; Heinrich G; Haber DA Genes Dev; 1995 Sep; 9(17):2143-56. PubMed ID: 7657166 [TBL] [Abstract][Full Text] [Related]
8. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity. Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497 [TBL] [Abstract][Full Text] [Related]
9. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1. Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912 [TBL] [Abstract][Full Text] [Related]
10. The nuclear localization signal of NGFI-A is located within the zinc finger DNA binding domain. Matheny C; Day ML; Milbrandt J J Biol Chem; 1994 Mar; 269(11):8176-81. PubMed ID: 8132543 [TBL] [Abstract][Full Text] [Related]
11. The speckling domain of the Wilms tumor suppressor WT1 overlaps with the transcriptional repression domain. Herzer U; Lutz B; Hartmann K; Englert C FEBS Lett; 2001 Apr; 494(1-2):69-73. PubMed ID: 11297737 [TBL] [Abstract][Full Text] [Related]
12. Characterization of RNA aptamer binding by the Wilms' tumor suppressor protein WT1. Zhai G; Iskandar M; Barilla K; Romaniuk PJ Biochemistry; 2001 Feb; 40(7):2032-40. PubMed ID: 11329270 [TBL] [Abstract][Full Text] [Related]
13. RNA binding by the Wilms tumor suppressor zinc finger proteins. Caricasole A; Duarte A; Larsson SH; Hastie ND; Little M; Holmes G; Todorov I; Ward A Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7562-6. PubMed ID: 8755514 [TBL] [Abstract][Full Text] [Related]
14. Overlapping RNA and DNA binding domains of the wt1 tumor suppressor gene product. Bardeesy N; Pelletier J Nucleic Acids Res; 1998 Apr; 26(7):1784-92. PubMed ID: 9512553 [TBL] [Abstract][Full Text] [Related]
15. Transcriptional activity of testis-determining factor SRY is modulated by the Wilms' tumor 1 gene product, WT1. Matsuzawa-Watanabe Y; Inoue J; Semba K Oncogene; 2003 Sep; 22(39):7900-4. PubMed ID: 12970737 [TBL] [Abstract][Full Text] [Related]
16. WT1, the Wilms' tumor suppressor gene product, represses transcription through an interactive nuclear protein. Wang ZY; Qiu QQ; Gurrieri M; Huang J; Deuel TF Oncogene; 1995 Mar; 10(6):1243-7. PubMed ID: 7700651 [TBL] [Abstract][Full Text] [Related]
17. The DNA binding domains of the WT1 tumor suppressor gene product and chimeric EWS/WT1 oncoprotein are functionally distinct. Kim J; Lee K; Pelletier J Oncogene; 1998 Feb; 16(8):1021-30. PubMed ID: 9519876 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of Wilms tumor 1 transactivation by bone marrow zinc finger 2, a novel transcriptional repressor. Lee TH; Lwu S; Kim J; Pelletier J J Biol Chem; 2002 Nov; 277(47):44826-37. PubMed ID: 12239212 [TBL] [Abstract][Full Text] [Related]
19. Analysis of native WT1 protein from frozen human kidney and Wilms' tumors. Iben S; Royer-Pokora B Oncogene; 1999 Apr; 18(15):2533-6. PubMed ID: 10229205 [TBL] [Abstract][Full Text] [Related]
20. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter. McCoy C; McGee SB; Cornwell MM Cell Growth Differ; 1999 Jun; 10(6):377-86. PubMed ID: 10392899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]